BioNTech/Pfizer vaccine is less potent against South African variant
Covid-19 jab still works but produces only a third of the antibodies it did for original virus, study finds
Full Article
BioNTech/Pfizer vaccine is less potent against South African variant
FT.com
0 shares
1 views
You might like
Related news coverage
-
Johnson ‘very confident’ in vaccines despite South African strain fears
Belfast Telegraph
-
Covid: Boris Johnson 'very confident' in vaccines being used in UK
BBC News
-
Pfizer/BioNTech vaccine effective against South African variant, study suggests
Belfast Telegraph
-
Covid: Scientists developing vaccine boosters to tackle variants
BBC News
Advertisement
More coverage
-
Coronavirus vaccine Q&A: Ask your questions on the South African variant and jabs at work
Telegraph.co.uk
-
Covid: Ministers seek to reassure public over Oxford-AstraZeneca vaccine
BBC Local News
-
Ministers seek to reassure over Oxford vaccine as concern grows over variants
Belfast Telegraph
-
Fears over South Africa variant raise prospect of autumn booster jab
Belfast Telegraph